Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank check company focused on the healthcare technology sector. The SPAC filed a Form 10-Q with the Securities and Exchange Commission on November 13, 2024, offering a quarterly snapshot of its financial position as it continued pursuing a business combination target. AFJK completed its initial public offering in 2023 and, as of the filing date, remained in its active search phase for an acquisition candidate in the health technology industry. The quarterly disclosure provides updated balance sheet and operational disclosures consistent with SPAC reporting obligations under SEC rules. Sign up at SpacDesk for full filing history, deal-stage tracking, and data coverage on AFJK and the broader SPAC universe.